Mutant Sodium Channel Nav1.7 and Methods Related Thereto
First Claim
1. A method of characterizing a nucleic acid sequence that encodes a Nav1.7 sodium channel alpha subunit, comprising the step of identifying mutations at one or more sites in regions of the nucleic acid sequence that encode an intracellular N-terminal region, an extracellular loop in domain I, an intracellular loop between domains I and U, an intracellular loop between domains II and III, an intramembrane region of domain II, or any combination thereof, such identified nucleotides indicating the character of the nucleic acid sequence.
3 Assignments
0 Petitions
Accused Products
Abstract
Described are mutant Nav1.7 sodium channel alpha-subunits and nucleic acid sequences encoding such mutants. Further described are methods for characterizing a nucleic acid sequence that encodes a Nav1 sodium channel alpha-subunit, methods for determining a Nav 1.7 haplotype, methods for determining a subject'"'"'s predisposition to a neurologic disorder associated with a sodium channel mutation, and methods of identifying a compound that modulates mutant Nav1.7 sodium channels. Other materials, compositions, articles, devices, and methods relating to mutant Nav1.7 sodium channels are also described herein.
-
Citations
88 Claims
- 1. A method of characterizing a nucleic acid sequence that encodes a Nav1.7 sodium channel alpha subunit, comprising the step of identifying mutations at one or more sites in regions of the nucleic acid sequence that encode an intracellular N-terminal region, an extracellular loop in domain I, an intracellular loop between domains I and U, an intracellular loop between domains II and III, an intramembrane region of domain II, or any combination thereof, such identified nucleotides indicating the character of the nucleic acid sequence.
-
27. A method for determining a Nav1.7 haplotype in a human subject comprising identifying one or more nucleotides encoding amino acid residues 62, 149, 641, 655, 739, 1123, or any combination thereof, wherein the nucleotide or nucleotides indicate the haplotype.
- 28. A method for determining a subject'"'"'s predisposition to a neurologic disorder associated with a sodium channel mutation comprising comparing the subject'"'"'s Nav1.7 haplotype with one or more reference haplotypes that correlate with the neurologic disorder, a similar haplotype in the subject'"'"'s Nav1.7 haplotype as compared to the reference haplotype or haplotypes indicating a predisposition to the neurologic disorder.
-
32. A method of identifying a compound that modulates mutant Nav1.7 sodium channels comprising:
-
a) contacting with a test compound a cell containing a mutant Nav1.7 nucleic acid that encodes a mutant Nav1.7 sodium channel comprising one or more mutations at residue 62, residue 149, residue 641, residue 655, residue 739, or residue 1123;
b) detecting Nav1.7 sodium channel activity; and
c) comparing the Nav1.7 sodium channel activity in the contacted cell with the amount of Nav1.7 sodium channel activity in a control cell, wherein the control cell is not contacted by the test compound, an increased or decreased Nav1.7 sodium channel activity in the test cell as compared to the control cell indicating a compound that modulates mutant Nav1.7 sodium channels.
-
- 33. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
38. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 2, wherein one of the amino acid residues comprises a valine in a position that corresponds to position 62 in SEQ ID NO;
2.
- 2, wherein one of the amino acid residues comprises a valine in a position that corresponds to position 62 in SEQ ID NO;
- 39. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
44. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 3, wherein one of the amino acid residues comprises a glutamine in a position that corresponds to position 149 in SEQ ID NO;
3.
- 3, wherein one of the amino acid residues comprises a glutamine in a position that corresponds to position 149 in SEQ ID NO;
- 45. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
50. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 4, wherein one of the amino acid residues comprises a tyrosine in a position that corresponds to position 641 in SEQ ID NO;
4.
- 4, wherein one of the amino acid residues comprises a tyrosine in a position that corresponds to position 641 in SEQ ID NO;
- 51. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
56. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 5, wherein one of the amino acid residues comprises a arginine in a position that corresponds to position 655 in SEQ ID NO;
5.
- 5, wherein one of the amino acid residues comprises a arginine in a position that corresponds to position 655 in SEQ ID NO;
- 57. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
62. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 6, wherein one of the amino acid residues comprises a valine in a position that corresponds to position 739 in SEQ ID NO;
6.
- 6, wherein one of the amino acid residues comprises a valine in a position that corresponds to position 739 in SEQ ID NO;
- 63. An isolated nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
-
67. A method of making a mutant Nav1.7 sodium channel alpha subunit comprising culturing the cell of claim 67 under conditions allowing expression of the polypeptide encoded by the nucleic acid, wherein the polypeptide comprises a mutant Nav1.7 sodium channel.
-
68. An isolated nucleic acid comprising a nucleotide sequence encoding at least 5 residues of the amino acid sequence of SEQ ID NO:
- 7, wherein one of the amino acid residues comprises a phenylalanine in a position that corresponds to position 1123 in SEQ ID NO;
7.
- 7, wherein one of the amino acid residues comprises a phenylalanine in a position that corresponds to position 1123 in SEQ ID NO;
-
69. A transgenic mouse comprising cells that encode a mutant Nav1.7 sodium channel alpha subunit, wherein the mouse exhibits increased seizure activity as compared to the wild-type mouse.
-
70. An isolated polypeptide comprising SEQ ID NO:
- 2.
-
71. An isolated polypeptide comprising SEQ ID NO:
- 32.
-
72. An isolated polypeptide comprising SEQ ID NO:
- 3.
-
73. An isolated polypeptide comprising SEQ ID NO:
- 33.
-
74. An isolated polypeptide comprising SEQ ID NO:
- 4.
-
75. An isolated polypeptide comprising SEQ ID NO:
- 34.
-
76. An isolated polypeptide comprising SEQ ID NO:
- 5.
-
77. An isolated polypeptide comprising SEQ ID NO:
- 35.
-
78. An isolated polypeptide comprising SEQ ID NO:
- 6.
-
79. An isolated polypeptide comprising SEQ ID NO:
- 36.
-
80. An isolated polypeptide comprising SEQ ID NO:
- 7.
-
81. An isolated polypeptide comprising SEQ ID NO:
- 37.
- 82. A purified antibody that selectively binds to an epitope of a mutant Nav1.7 sodium channel alpha subunit.
Specification